Net Asset Value(s)

Summary by AI BETAClose X

The Biotech Growth Trust reported an estimated unaudited net asset value per share of 1,542.24p (cum income) at the close of business on 9 November 2026, calculated in accordance with Association of Investment Companies guidelines; this NAV update, released 10 November 2026, is the primary market valuation metric and may influence the Trust's share price by affecting its discount/premium to NAV.

Disclaimer*

UK 100

Latest directors dealings